Article
Amgen's Lumakras/immunotherapy combo data held for August lung cancer meeting
Rating:
0.0
Views:
56
Likes:
1
Library:
1
Early trial data on Amgen Inc's Lumakras was released on Tuesday by the World Conference on Lung Cancer (WCLC), but meeting organizers decided to hold until Aug. 7 results from a highly anticipated study in combination with drugs that help the immune system attack cancer.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value